Royal Philips (NYSE:PHG) said today that it inked a 10-year strategic partnership deal with Rutherford Diagnostics to offer advanced diagnostics services across the UK.
Through the partnership deal, Philips will supply radiology technology while Rutherford will provide healthcare expertise through five new diagnostics centers across the UK, the companies said.
“For Philips, a successful managed service uses technology as an enabler to drive improved clinical practices and patient outcomes through innovation and sustainability. We believe this partnership with Rutherford Diagnostics is an opportunity to deliver a truly patient-centric diagnostic service with high levels of staff satisfaction. Philips already has a number of innovative managed service agreements with NHS partners here in the UK, so this is an exciting expansion of this service for us, as we partner with our first private provider,” Philips UK solutions lead Stephen McMillan said in a prepared release.
The first three centers are slated to launch in 2020, while the final two centers will launch in 2021, Amsterdam-based Philips said. The first site slated to open is in Liverpool, the company added.
“Our focus is to change the current healthcare paradigm from a reactive model which responds to disease, to one that is proactive and preventative with far reaching long-term benefits. We required a strategic partner who will complement our diagnostic service offering with technological innovation. Philips is closely aligned to our vision and can manage complexity while remaining flexible and is the right partner to support us on this journey,” Rutherford Diagnostics CEO Dr Steven Powell said in a press release.
Earlier this month, Philips and Medtronic (NYSE:MDT) inked a deal to integrate the Dutch firm’s Kodex EPD cardiac imaging guidance with Medtronic’s Arctic Front Advance cryoablation catheter.
